Abstract
Background/Objective
It is frequently recommended that urine output following perioperative mannitol administration be replaced 1:1 with an isotonic crystalloid solution. It is possible that this strategy could increase brain water by reducing the serum osmolality achieved with prior mannitol administration. Therefore, brain water content of rats treated with mannitol alone or mannitol plus normal saline (NS) was studied over a range of urinary replacement ratios.
Methods
Male Wister rats received mannitol 3.2 gm/100 gm infused over 45 min followed by hourly determinations of urine output (UO). Control animals received no additional therapy, whereas animals undergoing intervention received hourly replacement of their urinary losses with 0.9% NS in decreasing NS:UO ratios (1:1, 1:2, 1:3). Three hours after completion of the mannitol infusion, a final tally of UO was made. At that time in all animals, blood was obtained for determination of hemoglobin and electrolyte concentrations and plasma osmolality. Following that, the animals were sacrificed to determine brain water content. Additional groups underwent the same protocol but for 5 h with 1:1 urinary replacement, or received a volume of NS equal to that of the mannitol administered to all other control and intervention animals.
Results
1:1 replacement of urinary loss with NS following mannitol administration was associated with brain water content indistinguishable from control animals receiving only a volume of NS equal to that of the mannitol administered to all other groups. Regression analysis demonstrated a decrease in the final brain water content of 0.67% (CI95 0.43–0.92, p < 0.001) per replacement level as NS:UO replacement ratios were decreased from 1:1 to 1:2 and, finally to 1:3. At the final NS:UO replacement ratio of 1:3, brain water content was indistinguishable from the control group receiving mannitol without NS replacement (p = 0.48) For 1:1 replacement following mannitol, brain water did not differ between experiments of 3 or 5 h duration (p = 0.52).
Conclusions
In rats, NS replacement of UO 1:1 following mannitol administration leads to brain water content no different than if NS had been given in place of mannitol. Only when the NS:UO replacement ratio was 1:3, brain water was similar to that of control animals receiving mannitol alone. The recommendation to replace UO 1:1 with an equal volume of isotonic crystalloid following perioperative mannitol administration must recognize how this strategy could elevate brain water content compared to less vigorous replacement of UO.
Similar content being viewed by others
References
Zornow MH, Scheller MS. In: Cottrell JE, Smith DS, editors. Intraoperative fluid management during craniotomy, anesthesia and neurosurgery, 4th edn. Philadelphia, Mosby, 2001, p. 237–49.
Jackson EK. In: Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Drugs affecting renal excretory function, goodman and gilman’s the pharmacological basis of therapeutics, 13th edn. New York: McGraw-Hill; 2017.
Wang LC, Papangelou A, Lin C, Mirski MA, Gottschalk A, Toung TJ. Comparison of equivolume, equiosmolar solutions of mannitol and hypertonic saline with or without furosemide on brain water content in normal rats. Anesthesiology. 2013;118:903–13.
James HE. The effect of intravenous fluid replacement on the response to mannitol in experimental cerebral edema: an analysis of intracranial pressure, serum osmolality, serum electrolytes, and brain water content. Acta Neurochir Suppl. 2006;96:125–9.
Roumelioti ME, Ing TS, Rondon-Berrios H, Glew RH, Khitan ZJ, Sun Y, Malhotra D, Raj DS, Agaba EI, Murata GH, Shapiro JI, Tzamaloukas AH. Principles of quantitative water and electrolyte replacement of losses from osmotic diuresis. Int Urol Nephrol. 2018;50:1263–70.
Papangelou A, Kulikowicz E, Toung TJK. Laryngeal mask airway for urine collection in anesthetized rats. J Anim Physiol Anim Nutr (Berl). 2017;101:427–8.
Thenuwara K, Todd MM, Brian JE Jr. Effect of mannitol and furosemide on plasma osmolality and brain water. Anesthesiology. 2002;96:416–21.
Elliott KA, Jasper H. Measurement of experimentally induced brain swelling and shrinkage. Am J Physiol. 1949;157:122–9.
Cottrell JE, Robustelli A, Post K, Turndorf H. Furosemide- and mannitol-induced changes in intracranial pressure and serum osmolality and electrolytes. Anesthesiology. 1977;47:28–30.
Manninen PH, Lam AM, Gelb AW, Brown SC. The effect of high-dose mannitol on serum and urine electrolytes and osmolality in neurosurgical patients. Can J Anaesth. 1987;34:442–6.
Wu CT, Chen LC, Kuo CP, Ju DT, Borel CO, Cherng CH, Wong CS. A comparison of 3% hypertonic saline and mannitol for brain relaxation during elective supratentorial brain tumor surgery. Anesth Analg. 2010;110:903–7.
Moritz ML. Why 0.9% saline is isotonic: understanding the aqueous phase of plasma and the difference between osmolarity and osmolality. Pediatr Nephrol. 2019;34:1299–300.
Rasouli M. Basic concepts and practical equations on osmolality: biochemical approach. Clin Biochem. 2016;49:936–41.
Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J. 1996;10:615–24.
Palma L, Bruni G, Fiaschi AI, Mariottini A. Passage of mannitol into the brain around gliomas: a potential cause of rebound phenomenon. A study on 21 patients. J Neurosurg Sci. 2006;50:63–6.
Sankar T, Assina R, Karis JP, Theodore N, Preul MC. Neurosurgical implications of mannitol accumulation within a meningioma and its peritumoral region demonstrated by magnetic resonance spectroscopy: case report. J Neurosurg. 2008;108:1010–3.
Paczynski RP. Osmotherapy. Basic concepts and controversies. Crit Care Clin. 1997;13:105–29.
Papangelou A, Toung TJ, Gottschalk A, Mirski MA, Koehler RC. Infarct volume after hyperacute infusion of hypertonic saline in a rat model of acute embolic stroke. Neurocrit Care. 2013;18:106–14.
Paczynski RP, Venkatesan R, Diringer MN, He YY, Hsu CY, Lin W. Effects of fluid management on edema volume and midline shift in a rat model of ischemic stroke. Stroke. 2000;31:1702–8.
Acknowledgements
The authors are grateful for a critical reading of the manuscript by C. David Mintz, MD, PhD, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA and for the editorial assistance of Claire Levine, MS, ELS, Manager, Editorial Services, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA.
Funding
Support for this work was provided from internal departmental sources.
Author information
Authors and Affiliations
Contributions
Dr. Gottschalk helped conceive the study, analyzed the data, drafted the article and approved its final form. Dr. Toung conceived the study, carried out the experiments, critically revised the manuscript and approved its final form.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
Ethical guidelines have been adhered to, in particular approval by the IACUC. The ARRIVE guidelines have been adhered to.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gottschalk, A., Toung, T.J.K. Effects of Volume Replacement for Urinary Losses from Mannitol Diuresis on Brain Water in Normal Rats. Neurocrit Care 35, 24–29 (2021). https://doi.org/10.1007/s12028-020-01132-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-020-01132-w